1. Papanicolaou DA 2000 Euthyroid Sick Syndrome and the role of cytokines. Rev Endocr Metab Disord 1:43-8
2. Ajjan RA, Watson PF, Findlay C, et al. 1998 The sodium iodide symporter gene and its regulation by cytokines found in autoimmunity. J.Endocrinol. 158:351-358
3. Simons PJ, Delemarre FG, Drexhage HA 1998 Antigen-presenting dendritic cells as regulators of the growth of thyrocytes: a role of interleukin-1beta and interleukin-6. Endocrinology 139:3148-3156
4. Ashizawa K, Yamashita S, Nagayama Y, et al. 1989 Interferon-gamma inhibits thyrotropin-induced thyroidal peroxidase gene expression in cultured human thyrocytes. J.Clin.Endocrinol.Metab. 69:475-477
5. Asakawa H, Hanafusa T, Kobayashi T, Takai S, Kono N, Tarui S 1992 Interferon-gamma reduces the thyroid peroxidase content of cultured human thyrocytes and inhibits its increase induced by thyrotropin. J.Clin.Endocrinol.Metab. 74:1331-1335
6. Yamashita S, Kimura H, Ashizawa K, et al. 1989 Interleukin-1 inhibits thyrotrophin-induced human thyroglobulin gene expression. J.Endocrinol. 122:177-183
7. Poth M, Tseng YC, Wartofsky L 1991 Inhibition of TSH activation of human cultured thyroid cells by tumor necrosis factor: an explanation for decreased thyroid function in systemic illness? Thyroid. 1:235-240
8. Yamazaki K, Yamada E, Kanaji Y, et al. 1996 Interleukin-6 (IL-6) inhibits thyroid function in the presence of soluble IL-6 receptor in cultured human thyroid follicles. Endocrinology 137:4857-4863
9. Hashimoto H, Igarashi N, Miyawaki T, Sato T 1995 Effects of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 on type I iodothyronine 5'-deiodination in rat thyroid cell line, FRTL-5. J.Interferon.Cytokine.Res. 15:367-375
10. Davies PH, Sheppard MC, Franklyn JA 1997 Inflammatory cytokines and type I 5'-deiodinase expression in phi1 rat liver cells. Mol.Cell Endocrinol. 129:191-198
11. Boelen A, Maas MA, Lowik CW, Platvoet MC, Wiersinga WM 1996 Induced illness in interleukin-6 (IL-6) knock-out mice: a causal role of IL-6 in the development of the low 3,5,3'-triiodothyronine syndrome. Endocrinology 137:5250-5254
12. Boelen A, Platvoet-ter SM, Wiersinga WM 1997 Immunoneutralization of interleukin-1, tumor necrosis factor, interleukin-6 or interferon does not prevent the LPS-induced sick euthyroid syndrome in mice. J.Endocrinol. 153:115-122
13. Wassen FW, Moerings EP, Van TH, De VE, Hennemann G, Everts ME 1996 Effects of interleukin-1 beta on thyrotropin secretion and thyroid hormone uptake in cultured rat anterior pituitary cells. Endocrinology 137:1591-1598
14. Lyson K, McCann SM 1991 The effect of interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinology. 54:262-266
15. Dubuis JM, Dayer JM, Siegrist-Kaiser CA, Burger AG 1988 Human recombinant interleukin-1 beta decreases plasma thyroid hormone and thyroid stimulating hormone levels in rats. Endocrinology 123:2175-2181
16. Pang XP, Hershman JM, Smith V, Pekary AE, Sugawara M 1990 The mechanism of action of tumour necrosis factor-alpha and interleukin 1 on FRTL-5 rat thyroid cells. Acta Endocrinol.(Copenh.) 123:203-210
17. Ozawa M, Sato K, Han DC, Kawakami M, Tsushima T, Shizume K 1988 Effects of tumor necrosis factor-alpha/cachectin on thyroid hormone metabolism in mice. Endocrinology 123:1461-1467
18. van Haasteren GA, van der Meer MJ, Hermus AR, et al. 1994 Different effects of continuous infusion of interleukin-1 and interleukin-6 on the hypothalamic-hypophysial-thyroid axis. Endocrinology 135:1336-1345
19. Girvent M, Maestro S, Hernandez R, et al. 1998 Euthyroid sick syndrome, associated endocrine abnormalities, and outcome in elderly patients undergoing emergency operation. Surgery 123:560-567
20. Murai H, Murakami S, Ishida K, Sugawara M 1996 Elevated serum interleukin-6 and decreased thyroid hormone levels in postoperative patients and effects of IL-6 on thyroid cell function in vitro. Thyroid. 6:601-606
21. Boelen A, Platvoet-ter SM, Wiersinga WM 1993 Association between serum interleukin-6 and serum 3,5,3'- triiodothyronine in nonthyroidal illness. J.Clin.Endocrinol.Metab. 77:1695-1699
22. van der Poll T, Romijn JA, Wiersinga WM, Sauerwein HP 1990 Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J.Clin.Endocrinol.Metab. 71:1567-1572
23. Chopra IJ, Sakane S, Teco GN 1991 A study of the serum concentration of tumor necrosis factor-alpha in thyroidal and nonthyroidal illnesses. J.Clin.Endocrinol.Metab. 72:1113-1116
24. Corssmit EP, Heyligenberg R, Endert E, Sauerwein HP, Romijn JA 1995 Acute effects of interferon-alpha administration on thyroid hormone metabolism in healthy men. J.Clin.Endocrinol.Metab. 80:3140-3144
25. Torpy DJ, Tsigos C, Lotsikas AJ, Defensor R, Chrousos GP, Papanicolaou DA 1998 Acute and delayed effects of a single-dose injection of interleukin-6 on thyroid function in healthy humans. Metabolism 47:1289-1293
26. Bartalena L, Grasso L, Brogioni S, Aghini-Lombardi F, Braverman LE, Martino E 1994 Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 78:423-7
27. Bartalena L, Brogioni S, Grasso L, et al. 1994 Interleukin-6: a marker of thyroid-destructive processes? J Clin Endocrinol Metab 79:1424-7
28. Muller AF, Drexhage HA, Berghout A 2001 Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev 22:605-30
29. Beever K, Bradbury J, Phillips D, et al. 1989 Highly sensitive assays of autoantibodies to thyroglobulin and to thyroid peroxidase. Clin Chem 35:1949-54
30. Amino N, Hagen SR, Yamada N, Refetoff S 1976 Measurement of circulating thyroid microsomal antibodies by the tanned red cell haemagglutination technique: its usefulness in the diagnosis of autoimmune thyroid diseases. Clin Endocrinol (Oxf) 5:115-25
31. Parkes AB, Othman S, Hall R, John R, Richards CJ, Lazarus JH 1994 The role of complement in the pathogenesis of postpartum thyroiditis. J Clin Endocrinol Metab 79:395-400
32. Dardenne M, Savino W, Gagnerault MC, Itoh T, Bach JF 1989 Neuroendocrine control of thymic hormonal production. I. Prolactin stimulates in vivo and in vitro the production of thymulin by human and murine thymic epithelial cells. Endocrinology 125:3-12
33. Cross RJ, Campbell JL, Roszman TL 1989 Potentiation of antibody responsiveness after the transplantation of a syngeneic pituitary gland. J Neuroimmunol 25:29-35
34. Elenkov IJ, Wilder RL, Bakalov VK, et al. 2001 IL-12, TNF-alpha, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab 86:4933-8
35. Piccinni MP, Giudizi MG, Biagiotti R, et al. 1995 Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J Immunol 155:128-33
36. Laskarin G, Strbo N, Sotosek V, et al. 1999 Progesterone directly and indirectly affects perforin expression in cytolytic cells. Am J Reprod Immunol 42:312-20
37. Szekeres-Bartho J, Kilar F, Falkay G, Csernus V, Torok A, Pacsa AS 1985 The mechanism of the inhibitory effect of progesterone on lymphocyte cytotoxicity: I. Progesterone-treated lymphocytes release a substance inhibiting cytotoxicity and prostaglandin synthesis. Am J Reprod Immunol Microbiol 9:15-8
38. Szekeres-Bartho J, Autran B, Debre P, Andreu G, Denver L, Chaouat G 1989 Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction. Cell Immunol 122:281-94
39. Szekeres-Bartho J, Wegmann TG 1996 A progesterone-dependent immunomodulatory protein alters the Th1/Th2 balance. J Reprod Immunol 31:81-95
40. Szekeres-Bartho J, Par G, Szereday L, Smart CY, Achatz I 1997 Progesterone and non-specific immunologic mechanisms in pregnancy. Am J Reprod Immunol 38:176-182
41. Dealtry GB, O'Farrell MK, Fernandez N 2000 The Th2 cytokine environment of the placenta. Int Arch Allergy Immunol 123:107-119
42. Gilmore W, Weiner LP, Correale J 1997 Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 158:446-451
43. Smith R, Thomson M 1991 Neuroendocrinology of the hypothalamo-pituitary-adrenal axis in pregnancy and the puerperium. Baillieres Clin Endocrinol Metab 5:167-186
44. Magiakou MA, Mastorakos G, Rabin D, Dubbert B, Gold PW, Chrousos GP 1996 Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: implications for the increase in psychiatric manifestations at this time. J Clin Endocrinol Metab 81:1912-1917
45. Ostensen M 1992 The effect of pregnancy on ankylosing spondylitis, psoriatic arthritis, and juvenile rheumatoid arthritis. Am J Reprod Immunol 28:235-237
46. Fisfalen ME, Palmer EM, Van Seventer GA, Soltani K, Sawai Y, Kaplan E, Hidaka Y, Ober C, DeGroot LJ 1997 Thyrotropin-receptor and thyroid peroxidase-specific T cell clones and their cytokine profile in autoimmune thyroid disease. J Clin Endocrinol Metab 82:3655-3663
47. Meeusen EN, Premier RR, Brandon MR 1996 Tissue-specific migration of lymphocytes: a key role for Th1 and Th2 cells? Immunol Today 17:421-424
48. Atkinson M, Bowman M, Campbell L, et al 1994 Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J Clin Invest 94:2125
49. Tough DF, Borrow P, Sprent J 1996 Induction of bystander T cell proliferation by viruses and type 1 interferon in vivo. Science 272:1947
50. Katz JD, Benoist C, Mathis D 1995 T helper cell subsets in insulin-dependent diabetes. Science 268:1185
51. Wilson SB, Kent SC, Patton KT, et al 1998 Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 391:177
52. Fernandez-Real JM, Broch M, Vendrell J, Gutierrez C, Casamitjana R, Pugeat M, Richart C, Ricart W 2000 Interleukin-6 gene polymorphism and insulin sensitivity. Diabetes 49:517-520.
53. Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, Tracy RP 2001 The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 50:2384-2389
54. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, Wallace RB, Jackson RD, Pettinger MB, Ridker PM 2002 Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA 288:980-987
55. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM 2001 C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286:327-334
56. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, Tyson K, Chrousos GP 1997 Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. Journal of Clinical Endocrinology and Metabolism 82:1313-1316
57. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A, Chrousos GP 2000 Sleep apnea and daytime sleepiness and fatigue: relations with visceral obesity, insulin resistance, and hypercytokinemia. Journal of Clinical Endocrinology and Metabolism 84:1151-1158
58. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G 2001 Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 280:E745-E751
59. Vicennati V, Vottero A, Friedman C, Papanicolaou DA 2002 Hormonal regulation of interleukin-6 production in human adipocytes. International Journal of Obesity and Related Metabolic Disorders 26:905-911
60. Tsigos C, Papanicolaou DA, Kyrou I, Raptis SA, Chrousos GP 1999 Dose-dependent effects of recombinant human interleukin-6 on the pituitary-testicular axis. Journal of Interferon and Cytokine Research 19:1271-1276
61. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM 1995 Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95:2409-2415
62. Hotamisligil GS, Shargill NS, Spiegelman BM 1993 Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259(5091):87-91
63. Hofmann C, Lorenz K, Braithwaite SS, Colca JR, Palazuk BJ, Hotamisligil GS, Spiegelman BM 1994 Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134:264-270
64. Vilcek J, Lee TH 1991 Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 266:7313-7316
65. Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM 1996 IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271(5249):665-668
66. Stephens JM, Pekala PH 1991 Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. J Biol Chem 266:21839-21845
67. Cornelius P, Lee MD, Marlowe M, Pekala PH 1989 Monokine regulation of glucose transporter mRNA in L6 myotubes. Biochem Biophys Res Commun 165:429-436
68. Spiegelman BM, Hotamisligil GS 1993 Through thick and thin: wasting, obesity, and TNF alpha. Cell 73:625-627
69. Feingold KR, Grunfeld C 1992 Role of cytokines in inducing hyperlipidemia. Diabetes 41(Suppl 2):97-101
70. Grunfeld C, Feingold KR 1991 The metabolic effects of tumor necrosis factor and other cytokines. Biotherapy 1991 3:143-158
71. Fernandez-Real JM, Broch M, Vendrell J, Rieart W 2000 Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J Clin Endocrinol Metab 85:1334-1339
72. Greenberg AS, Nordan RP, McIntosh J, Calvo JC, Scow RO, Jablons D 1992 Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. Cancer Res. 52:4113-4116
73. Akgun S, Ertel NH, Mosenthal A, Oser W 1998 Postsurgical reduction of serum lipoproteins: interleukin-6 and the acute-phase response. J Lab Clin Med 131:103-108
74. Hill GE, Pohorecki R, Whitten CW 1998 Plasma lipid concentrations correlate inversely with CPB-induced interleukin-6 release. Can J Anaesth 45:509-514
75. Bologa RM, Levine DM, Parker TS, et al 1998 Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32:107-114
76. Brugada R, Wenger NK, Jacobson TA, Clark WS, Cotsonis G, Iglesias A 1996 Changes in plasma cholesterol levels after hospitalization for acute coronary events. Cardiology 87:194-199
77. Papanicolaou DA and Vgontzas AN 2000 Interleukin-6: The endocrine cytokine. Journal of Clinical Endocrinology and Metabolism 84:1331-1333
78. Manolagas SC, Jilka RL 1995 Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305-311
79. Mundy GR 1992 Local factors regulating osteoclast function. In: Rifkin BR, Gay CV, eds. Biology and physiology of the osteoclast. Boca Raton, Fla.: CRC Press 171-185
80. Horowitz MC, Jilka RL 1992 Colony stimulating factors and bone remodeling. In: Gowen M, ed. Cytokines and bone metabolism. Boca Raton, Fla.: CRC Press:185-227
81. Girasole G, Passeri G, Jilka RL, Manolagas SC 1994 Interleukin-11: a new cytokine critical for osteoclast development. J Clin Invest 93:1516-1524
82. Demulder A, Suggs SV, Zsebo KM, Scarcez T, Roodman GD 1992 Effects of stem cell factor on osteoclast-like cell formation in long-term human marrow cultures. J Bone Miner Res 7:1337-1344
83. Manolagas SC, Jilka RL, Girasole G, Passeri G, Bellido T 1994 Estrogens, cytokines, and the pathophysiology of osteoporosis. In: Kohler PO, ed. Current opinion in endocrinology and diabetes. Philadelphia: Current Science:275-281
84. Ishimi Y, Miyaura C, Jin CH, et al 1990 IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 145:3297-3303
85. Lowik CW, van der Pluijm G, Bloys H, et al 1989 Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun 162:1546-1552
86. Black K, Garrett IR, Mundy GR 1991 Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice. Endocrinology 128:2657-2659
87. Ohsaki Y, Takahashi S, Scarcez T, et al 1992 Evidence for an autocrine/paracrine role for interleukin-6 in bone resorption by giant cells from giant cell tumors of bone. Endocrinology 131:2229-2234
88. Klein B, Wijdenes J, Zhang X-G, et al 1991 Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia. Blood 78:1198-1204
89. Roodman GD, Kurihara N, Ohsaki Y, et al 1992 Interleukin 6: a potential autocrine/paracrine factor in Paget's disease of bone. J Clin Invest 89:46-52
90. Kotake S, Sato K, Kim KJ, et al 1994 Interleukin-6 and soluble interleukin-6 receptors found in synovial fluids are responsible for inducing joint disruption in patients with rheumatoid arthritis. J Bone Miner Res 9:Suppl 1:S140. abstract
91. Devlin RD, Bone HG III, Roodman GD 1994 Stimulation of osteoclast-like multinucleated cell (MNC) formation in long-term human bone marrow culture by the serum of patients with Gorham-Stout or disappearing bone disease. J Bone Miner Res 9:Suppl 1:S140. abstract
92. Martin TJ, Allan EH, Evely RS, Reid IR 1992 Leukaemia inhibitory factor and bone cell function. Ciba Found Symp 167:141-155
93. Girasole G, Jilka RL, Passeri G, et al 1992 17(beta)-Estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89:883-891
94. Pottratz S, Bellido T, Mocharla H, Crabb D, Manolagas SC 1994 17(beta)-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism J Clin Invest 93:944-950
95. Ray A, Prefontaine KE, Ray P 1994 Down-modulation of interleukin-6 gene expression by 17 beta-estradiol in the absence of high affinity DNA binding by the estrogen receptor. J Biol Chem 269:12940-12946
96. Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, et al 1994 Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 13:1189-1196
97. Bellido T, Jilka RL, Boyce BF, Girasole G, Broxmeyer H, Dalrymple SA, et al 1995 Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. J Clin Invest 95:2886-2895
98. Cenci S, Weitzmann MN, Roggia C, Namba N, Novack D, Woodring J, Pacifici R 2000 Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest 106:1229-1237
99. Roggia C, Gao Y, Cenci S, Weitzmann MN, Toraldo G, Isaia G, Pacifici R 2001 Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci U S A 2001 98:13960-13965
100. van Deventer SJ, Buller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A 1990 Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 76:2520-2526
101. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA 1990 Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 75:40-47
102. Srivastava S, Weitzmann MN, Cenci S, Ross FP, Adler S, Pacifici R 1999 Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J Clin Invest 104:503-513
103. Gilbert L, He X, Farmer P, Rubin J, Drissi H, van Wijnen AJ, Lian JB, Stein GS, Nanes MS 2002 Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha. J Biol Chem 277:2695-2701
104. Weitzmann MN, Cenci S, Rifas L, Brown C, Pacifici R 2000 Interleukin-7 stimulates osteoclast formation by up-regulating the T-cell production of soluble osteoclastogenic cytokines. Blood 96:1873-1878.
105. Siddiqi A, Burrin JM, Wood DF, Monson JP 1998 Tri-iodothyronine regulates the production of interleukin-6 and interleukin-8 in human bone marrow stromal and osteoblast-like cells. J Endocrinol 157:453-461.
106. Siddiqi A, Monson JP, Wood DF, Besser GM, Burrin JM 1999 Serum cytokines in thyrotoxicosis. J Clin Endocrinol Metab 84:435-439.
107. Grey A, Mitnick MA, Shapses S, Ellison A, Gundberg C, Insogna K 1996 Circulating levels of interleukin-6 and tumor necrosis factor-alpha are elevated in primary hyperparathyroidism and correlate with markers of bone resorption--a clinical research center study. J Clin Endocrinol Metab 81:3450-3454.
108. Taga T 1997 The signal transducer gp130 is shared by the interleukin-6 family of hematopoietic and neurotrophic cytokines. Ann Med 29:63-72
109. Benigni F, Fantuzzi G, Sacco S, et al. 1996 Six different cytokines that share gp130 as a receptor subunit, induce serum amyloid A and potentiate the induction of interleukin-6 and the activation of the hypothalamic-pituitary adrenal axis by interleukin-1. Blood 87:1851-1854
110. Romas E, Udagawa N, Zhou H, et al. 1996 The role of gp-130 mediated signals in osteoclast development: regulation of interleukin-11 production by osteoblasts and distributiion of its receptor in bone marrow cultures. J Exp Med 183:2581-2591[Abstract]
111. Shih C, Tsai C, Shyu J, Chu P 1998 Interleukin-11 stimulates osteoclast formation and inhibits osteoclast apoptosis. Bone 23(Suppl 5):S224
112. Girasole G, Vescovini R, Giuliani N, et al. 1998 IL-6 and IL-11 are protective against apoptosis mediated by Fas/Apo-1 in human osteoclast-like cells GCT-51. Potential involovement of the gp130 signal transducer. Bone 23(Suppl 5):S438
113. Nakchbandi IA, Mitnick MA, Masiukiewicz US, Sun BH, Insogna KL 2001 IL-6 negatively regulates IL-11 production in vitro and in vivo. Endocrinology 142:3850-3856.
114. Lyson K, McCann SM 1991 The effect of interleukin-6 on pituitary hormone release in vivo and in vitro. Neuroendocrinology 54:262-266.
115. Vankelecom H, Carmeliet P, Van Damme J, Billiau A, Denef C 1989 Production of interleukin-6 by folliculo-stellate cells of the anterior pituitary gland in a histiotypic cell aggregate culture system. Neuroendocrinology 49:102-106.
116. Perlstein RS, Whitnall MH, Abrams JS, Mougey EH, Neta R 1993 Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology 132:946-952.
117. Sothern RB, Roitman-Johnson B, Kanabrocki EL, Yager JG, Fuerstenberg RK, Weatherbee JA, Young MR, Nemchausky BM, Scheving LE 1995 Circadian characteristics of interleukin-6 in blood and urine of clinically healthy men. In Vivo 9:331-339.
118. Papanicolaou DA, Tsigos C, Oldfield EH, Chrousos GP 1996 Acute glucocorticoid deficiency is associated with plasma elevations of interleukin-6: does the latter participate in the symptomatology of the steroid withdrawal syndrome and adrenal insufficiency? Journal of Clinical Endocrinology and Metabolism 81:2303-2306.
119. Tsigos C, Papanicolaou DA, Defensor R, Mitsiadis CS, Kyrou I, Chrousos GP 1997 Dose effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroendocrinology, 66:54-62.
120. Auernhammer CJ, Melmed S 2000 Leukemia-inhibitory factor-neuroimmune modulator of endocrine function. Endocr Rev 21:313-345.
121. Van Gool J, Van Vugt H, Helle M, Aarden LA. 1990 The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat. Clin Immunol Immunopathol 57:200-210.
122. Papanicolaou DA, Petrides JS, Tsigos C, Bina S, Kalogeras KT, Wilder R, Gold PW, Deuster PA, Chrousos GP 1996 Exercise stimulates the secretion of interleukin-6: inhibition by glucocorticoids and correlation with catecholamines. American Journal of Physiology 271:E601-E605.